509 related articles for article (PubMed ID: 22580654)
21. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial.
Liu ZM; Chen J; Kou Q; Lin Q; Huang X; Tang Z; Kang Y; Li K; Zhou L; Song Q; Sun T; Zhao L; Wang X; He X; Wang C; Wu B; Lin J; Yuan S; Gu Q; Qian K; Shi X; Feng Y; Lin A; He X; ; Guan XD
Intensive Care Med; 2018 Nov; 44(11):1816-1825. PubMed ID: 29971593
[TBL] [Abstract][Full Text] [Related]
22. Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock.
Zeballos G; López-Herce J; Fernández C; Brandstrup KB; Rodríguez-Núñez A
Resuscitation; 2006 Jan; 68(1):151-3. PubMed ID: 16325320
[TBL] [Abstract][Full Text] [Related]
23. Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury.
Salluh JI; Martins GA; Santino MS; Araújo LV; Freitas GG; Verdeal JC
Acta Anaesthesiol Scand; 2007 Apr; 51(4):505-8. PubMed ID: 17378791
[TBL] [Abstract][Full Text] [Related]
24. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children.
Yildizdas D; Yapicioglu H; Celik U; Sertdemir Y; Alhan E
Intensive Care Med; 2008 Mar; 34(3):511-7. PubMed ID: 18092150
[TBL] [Abstract][Full Text] [Related]
25. Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock.
Rodríguez-Núñez A; Oulego-Erroz I; Gil-Antón J; Pérez-Caballero C; López-Herce J; Gaboli M; Milano G;
Ann Pharmacother; 2010 Oct; 44(10):1545-53. PubMed ID: 20841511
[TBL] [Abstract][Full Text] [Related]
26. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
27. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock.
Morelli A; Rocco M; Conti G; Orecchioni A; De Gaetano A; Cortese G; Coluzzi F; Vernaglione E; Pelaia P; Pietropaoli P
Intensive Care Med; 2004 Apr; 30(4):597-604. PubMed ID: 14673520
[TBL] [Abstract][Full Text] [Related]
28. Terlipressin bolus induces systemic vasoconstriction in septic shock.
Peters MJ; Booth RA; Petros AJ
Pediatr Crit Care Med; 2004 Mar; 5(2):112-5. PubMed ID: 14987338
[TBL] [Abstract][Full Text] [Related]
29. Terlipressin: vasopressin analog and novel drug for septic shock.
Pesaturo AB; Jennings HR; Voils SA
Ann Pharmacother; 2006 Dec; 40(12):2170-7. PubMed ID: 17148649
[TBL] [Abstract][Full Text] [Related]
30. Terlipressin as rescue treatment of refractory shock in a neonate.
Filippi L; Poggi C; Serafini L; Fiorini P
Acta Paediatr; 2008 Apr; 97(4):500-2. PubMed ID: 18307552
[TBL] [Abstract][Full Text] [Related]
31. Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.
Morelli A; Donati A; Ertmer C; Rehberg S; Orecchioni A; Di Russo A; Pelaia P; Pietropaoli P; Westphal M
Intensive Care Med; 2011 Jun; 37(6):963-9. PubMed ID: 21336777
[TBL] [Abstract][Full Text] [Related]
32. Arginine vasopressin vs. terlipressin in the treatment of shock states.
Singer M
Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):359-68. PubMed ID: 18683481
[TBL] [Abstract][Full Text] [Related]
33. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
[TBL] [Abstract][Full Text] [Related]
34. Effects of terlipressin on microcirculation of small bowel mesentery in rats with endotoxic shock.
Qiu X; Huang Y; Xu J; Qiu H; Yang Y
J Surg Res; 2014 May; 188(2):503-9. PubMed ID: 24582066
[TBL] [Abstract][Full Text] [Related]
35. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
Saner FH; Canbay A; Gerken G; Broelsch CE
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):207-17. PubMed ID: 19072411
[TBL] [Abstract][Full Text] [Related]
36. Use of heptaminol hydrochloride for catecholamine weaning in septic shock.
Bahloul M; Chaari A; Ben Mbarek MN; Kallel H; Bouaziz M
Am J Ther; 2012 Jan; 19(1):e8-17. PubMed ID: 20720484
[TBL] [Abstract][Full Text] [Related]
37. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
[TBL] [Abstract][Full Text] [Related]
38. [Vasopressin and its analogues in the therapy of shock].
Novák F; Lubanda H; Onderková R; Zák A
Cas Lek Cesk; 2004; 143(5):307-8, 310-2. PubMed ID: 15305765
[TBL] [Abstract][Full Text] [Related]
39. Sublingual microcirculatory flow is impaired by the vasopressin-analogue terlipressin in a patient with catecholamine-resistant septic shock.
Boerma EC; van der Voort PH; Ince C
Acta Anaesthesiol Scand; 2005 Oct; 49(9):1387-90. PubMed ID: 16146482
[TBL] [Abstract][Full Text] [Related]
40. Effects of terlipressin on patients with sepsis via improving tissue blood flow.
Xiao X; Zhang J; Wang Y; Zhou J; Zhu Y; Jiang D; Liu L; Li T
J Surg Res; 2016 Jan; 200(1):274-82. PubMed ID: 26253455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
